Canada markets open in 7 hours 36 minutes

Bionano Genomics, Inc. (BNGO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.6200+0.2800 (+8.38%)
At close: 04:00PM EST
3.6600 +0.04 (+1.10%)
After hours: 07:59PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 983.23M
Enterprise Value 636.03M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)53.18
Price/Book (mrq)2.88
Enterprise Value/Revenue 40.59
Enterprise Value/EBITDA -11.08

Trading Information

Stock Price History

Beta (5Y Monthly) 1.87
52-Week Change 3554.90%
S&P500 52-Week Change 325.02%
52 Week High 315.6900
52 Week Low 30.4900
50-Day Moving Average 34.9494
200-Day Moving Average 36.2491

Share Statistics

Avg Vol (3 month) 38.77M
Avg Vol (10 day) 39.84M
Shares Outstanding 5289.18M
Implied Shares Outstanding 6N/A
Float 8280.78M
% Held by Insiders 12.17%
% Held by Institutions 125.31%
Shares Short (Nov. 14, 2021) 437.5M
Short Ratio (Nov. 14, 2021) 44.12
Short % of Float (Nov. 14, 2021) 412.97%
Short % of Shares Outstanding (Nov. 14, 2021) 412.97%
Shares Short (prior month Oct. 14, 2021) 442.03M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Sep. 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)-369.80%

Management Effectiveness

Return on Assets (ttm)-18.06%
Return on Equity (ttm)-34.37%

Income Statement

Revenue (ttm)15.67M
Revenue Per Share (ttm)0.06
Quarterly Revenue Growth (yoy)112.00%
Gross Profit (ttm)2.77M
EBITDA -55.88M
Net Income Avi to Common (ttm)-61.22M
Diluted EPS (ttm)-0.2500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)326.07M
Total Cash Per Share (mrq)1.13
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)19.32
Book Value Per Share (mrq)1.21

Cash Flow Statement

Operating Cash Flow (ttm)-58.41M
Levered Free Cash Flow (ttm)-28.41M